76.57MMarket Cap-0.59P/E (TTM)
6.176High5.654Low24.63KVolume5.900Open5.630Pre Close145.69KTurnover0.59%Turnover RatioLossP/E (Static)13.34MShares19.99952wk High0.64P/B24.01MFloat Cap4.57552wk Low--Dividend TTM4.18MShs Float171.799Historical High--Div YieldTTM9.27%Amplitude4.575Historical Low5.914Avg Price1Lot Size
OnKure Therapeutics Stock Forum
Onkure Therapeutics Inc - Oki-219 Well Tolerated With No Hyperglycemia and Only Grade 1 Traes
SC 13G: Statement of acquisition of beneficial ownership by individuals-Kenneth Griffin(9.9%),Citadel Advisors LLC(9.8%), etc.
SEC 17:29
SC 13G: Statement of acquisition of beneficial ownership by individuals-Cormorant Asset Management, LP(14.98%),Bihua Chen(14.98%), etc.
SEC 16:24
SC 13G: Statement of acquisition of beneficial ownership by individuals-Samsara BioCapital, L...
No comment yet